Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05961332 · ClinicalTrials.gov registry record · NA
COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Geographic Atrophy
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT05961332 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 62 participants.
The verdict
NCT05961332, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to compare measurements of geographic atrophy (GA) area between several types of imaging, in order to assess accuracy. The main question to answer is which imaging device provides measurements that are most similar to the standard of care device. Participants will be patients of a retina doctor at University Station Eye Clinic with geographic atrophy, and can expect to be in the study for 60-75 minutes.
Interventions
- DEVICE Spectralis FAF imaging
- DEVICE Optos imaging
- DEVICE Zeiss Clarus 700 imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2023-10-06 |
| Est. Completion | 2025-05-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05961332
The ClinicalTrials.gov registry entry for NCT05961332 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Spectralis FAF imaging is the first listed.
NCT05961332 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05961332 about?
NCT05961332 is a clinical study titled "COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Geographic Atrophy". The goal of this clinical trial is to compare measurements of geographic atrophy (GA) area between several types of imaging, in order to assess accuracy. The main question to answer is which imaging device provides measurements that are most similar to the standard of care device. Participants will...
What is the current status of trial NCT05961332?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2023-10-06. Estimated completion is 2025-05-27.
What interventions are being tested in trial NCT05961332?
The interventions under investigation include: Spectralis FAF imaging (DEVICE), Optos imaging (DEVICE), Zeiss Clarus 700 imaging (DEVICE).
Who is sponsoring clinical trial NCT05961332?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.